Contract research organisation (CRO), Reaction Biology, has partnered with an open science drug discovery and development company, M4K Pharma, in the fight against diffuse intrinsic pontine glioma (DIPG) — a rare paediatric brain cancer.
Brain tumour research
This partnership will use a novel open science non-profit business model that encourages collaboration and sharing to help treat childhood diseases believed to be commercially prohibitive for conventional drug discovery companies.